Shopping Cart
- Remove All
- Your shopping cart is currently empty
Pasotuxizumab (BAY 2010112) is a bispecific T-cell engager (BiTE) targeting PSMA and CD3, with dissociation constants (K D) of 47.0 nM for PSMA and 9.4 nM for CD3. It is used in the study of metastatic castration-resistant prostate cancer (mCRPC) [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Pasotuxizumab (BAY 2010112) is a bispecific T-cell engager (BiTE) targeting PSMA and CD3, with dissociation constants (K D) of 47.0 nM for PSMA and 9.4 nM for CD3. It is used in the study of metastatic castration-resistant prostate cancer (mCRPC) [1] [2]. |
Cas No. | 1442657-12-6 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.